Clinical Role - Specialty Pharmacy

Pharmacy Times® is a leader in providing expert insights and clinical updates to specialty pharmacists and reaches more than 200,000 pharmacy professionals in total.

The shift from fee-for-service to a value-based care payment model represents the growing understanding of the value of health care providers in improving overall patient outcomes.
The release of generic versions of brand name drugs for patients with multiple sclerosis had little overall effect on the price increase.
Top news of the day from across the health care landscape.
Specialty Pharmacy Program
Annette Hood, PharmD, BCACP, discusses the role of special pharmacy programs to manage the administration of oral chemotherapy and PARP inhibitors, and emphasizes the impact medication assistance technicians have on mitigating treatment costs for patients.
Margetuximab plus chemotherapy showed positive results in a second pre-specified interim overall survival analysis for the phase 3 SOPHIA study.
Top news of the day from across the health care landscape.
Antiretroviral therapy may not be entirely effective in restoring the immune protection resulting from viral infections or childhood vaccines received prior to becoming HIV-positive.
The report projects changes in upcoming health care markets, including kidney care, digital health, drug cost transparency, the loneliness epidemic, and the self-care market.
The findings support the inclusion of these patient populations in ICI-based clinical trials and treatment.
Safety net providers, which historically work in underserved communities, have successfully petitioned state legislatures to take action on 340B 2-tier pricing.
VELIA Regimen
Expert oncologists discuss the VELIA study and the new frontline PARP inhibitor treatment veliparib.